Ataxia and peripheral nerve hypomyelination in ADAM22-deficient mice

por Sagane, Koji, Hayakawa, Kazuhiro, Kai, Junko, Hirohashi, Tomoko, Takahashi, Eiki, Miyamoto, Norimasa, Ino, Mitsuhiro, Oki, Tohru, Yamazaki, Kazuto, Nagasu, Takeshi
Publicado 2005

A phase I study of the human anti‐activin receptor‐like kinase 1 antibody PF‐03446962 in Asian patients with advanced solid tumors

por Doi, Toshihiko, Lee, Kyung‐Hun, Kim, Tae‐Min, Ohtsu, Atsushi, Kim, Tae Yong, Ikeda, Masafumi, Yoh, Kiyotaka, Gallo Stampino, Corrado, Hirohashi, Tomoko, Suzuki, Akiyuki, Fujii, Yosuke, Andrew Williams, James, Bang, Yung‐Jue
Publicado 2016

Induced pluripotent stem cell–based Drug Repurposing for Amyotrophic lateral sclerosis Medicine (iDReAM) study: protocol for a phase I dose escalation study of bosutinib for amyotr...

por Imamura, Keiko, Izumi, Yuishin, Banno, Haruhiko, Uozumi, Ryuji, Morita, Satoshi, Egawa, Naohiro, Ayaki, Takashi, Nagai, Makiko, Nishiyama, Kazutoshi, Watanabe, Yasuhiro, Hanajima, Ritsuko, Oki, Ryosuke, Fujita, Koji, Takahashi, Naoto, Ikeda, Takafumi, Shimizu, Akira, Morinaga, Akiko, Hirohashi, Tomoko, Fujii, Yosuke, Takahashi, Ryosuke, Inoue, Haruhisa
Publicado 2019

Safety and tolerability of bosutinib in patients with amyotrophic lateral sclerosis (iDReAM study): A multicentre, open-label, dose-escalation phase 1 trial

por Imamura, Keiko, Izumi, Yuishin, Nagai, Makiko, Nishiyama, Kazutoshi, Watanabe, Yasuhiro, Hanajima, Ritsuko, Egawa, Naohiro, Ayaki, Takashi, Oki, Ryosuke, Fujita, Koji, Uozumi, Ryuji, Morinaga, Akiko, Hirohashi, Tomoko, Fujii, Yosuke, Yamamoto, Takuya, Tatebe, Harutsugu, Tokuda, Takahiko, Takahashi, Naoto, Morita, Satoshi, Takahashi, Ryosuke, Inoue, Haruhisa
Publicado 2022